Deborah A. Scollard

Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments

Ying Tang, Judy Wang, Deborah A. Scollard et al. · Nuclear Medicine and Biology · 2005 · 141 citations

Medicine, Molecular Biology, Oncology +14

Associations between the uptake of 111In-DTPA-trastuzumab, HER2 density and response to trastuzumab (Herceptin) in athymic mice bearing subcutaneous human tumour xenografts

Kristin McLarty, Bart Cornelissen, Deborah A. Scollard et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 126 citations

Medicine, Oncology, Pharmacology +14

Role of Antibody-Mediated Tumor Targeting and Route of Administration in Nanoparticle Tumor Accumulation in Vivo

Niladri Chattopadhyay, Humphrey Fonge, Zhongli Cai et al. · Molecular Pharmaceutics · 2012 · 116 citations

Pharmacy, Oncology, Pharmaceutics +17

Micro-SPECT/CT with ¹¹¹In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated <i>HER2</i> Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts

Kristin McLarty, Bart Cornelissen, Zhongli Cai et al. · Journal of Nuclear Medicine · 2009 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Oncolytic Vaccinia Virus Expressing the Human Somatostatin Receptor SSTR2: Molecular Imaging after Systemic Delivery Using 111In-Pentetreotide

J. Andrea McCart, Navneet Mehta, Deborah A. Scollard et al. · Molecular Therapy · 2004 · 77 citations · Full text

Medicine, Cancer Biology, Oncology +17